Metraipolis › archive › dc_1c889f6bb035

Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma — Europe PMC PMID:41149461

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41149461
DOI
10.3390/curroncol32100541
License (as archived)
solo-consultazione
Archived
2026-11-09T17:32:46.079Z
SHA-256 of the archived text
31717ff2ffc4c19b5f175d6dda8ec06a117b180e186b36dfac4a010ba148346b
Stable URL of this page
https://metraipolis.com/documento/dc_1c889f6bb035

How to cite

Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma — Europe PMC PMID:41149461 — Europe PMC (en), https://europepmc.org/article/MED/41149461 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1c889f6bb035 (Metraipolis archive dc_1c889f6bb035, sha256 31717ff2ffc4c19b5f175d6dda8ec06a117b180e186b36dfac4a010ba148346b)
BibTeX
@misc{dc1c889f6bb035,
  title = {Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma — Europe PMC PMID:41149461},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41149461},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1c889f6bb035; sha256 31717ff2ffc4c19b5f175d6dda8ec06a117b180e186b36dfac4a010ba148346b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41149461. Agents can read the archived copy with the MCP tool read_document.